Tackling Mis-and Disinformation in the Context of Scientific Uncertainty: The Ongoing Case of the COVID-19 ‘Infodemic’

Author(s):  
Mihalis Kritikos
2020 ◽  
Vol 47 (1) ◽  
pp. 7-11
Author(s):  
Maud O. Jansen ◽  
Peter Angelos ◽  
Stephen J. Schrantz ◽  
Jessica S. Donington ◽  
Maria Lucia L. Madariaga ◽  
...  

Clinical trials emerged in rapid succession as the COVID-19 pandemic created an unprecedented need for life-saving therapies. Fair and equitable subject selection in clinical trials offering investigational therapies ought to be an urgent moral concern. Subject selection determines the distribution of risks and benefits, and impacts the applicability of the study results for the larger population. While Research Ethics Committees monitor fair subject selection within each trial, no standard oversight exists for subject selection across multiple trials for the same disease. Drawing on the experience of multiple clinical trials at a single academic medical centre in the USA, we posit that concurrent COVID-19 trials are liable to unfair and inequitable subject selection on account of scientific uncertainty, lack of transparency, scarcity and, lastly, structural barriers to equity compounded by implicit bias. To address the critical gap in the current literature and international regulation, we propose new ethical guidelines for research design and conduct that bolsters fair and equitable subject selection. Although the proposed guidelines are tailored to the research design and protocol of concurrent trials in the COVID-19 pandemic, they may have broader relevance to single COVID-19 trials.


2021 ◽  
pp. 1-17
Author(s):  
Muhammad ISLAM

The World Trade Organization (WTO) Agreement on the Application of Sanitary and Phytosanitary Measures (SPS Agreement) relies on scientific evidence as a conclusive risk assessment criterion, which ignores the inherent limitations of science. This article highlights certain trade-restrictive effects of scientific evidence and comments on the Agreement’s aversions to precautionary measures and the consumer concern of the harmful effects of biotech products that may be necessary to protect public health and biosecurity in many WTO Member States. These measures and concerns have become pressing issues due to surging consumer awareness and vigilance concerning environmental protection and food safety. The Agreement is yet to overcome the weaknesses of its endorsed international standardising bodies, the problematic definition of scientific evidence and treatment of justification for scientific risk assessment methods and the implementation difficulties faced by most developing states. This article analyses these issues under the provisions of the Agreement and the interpretations of the WTO Dispute Settlement Body in disputes involving SPS matters, which fall short of addressing scientific uncertainty surrounding biotech products and their associated risks.


Author(s):  
David O. Carpenter

The world economy has been growing by an average of 3.5% a year. Continued global development is sustainable if overall social assets remain constant or rise over time, including manufactured, human, and environmental capital. Sustainable development requires that society not decrease its overall assets. But unregulated global trade may result in long-term loss of environmental capital. Multilateral governance is needed. Classical business models tend to view environmental damage as an externality—an impact on a third party's welfare that is neither compensated nor appropriated. The Rio Declaration on Environment and Development clearly states that economic development must err on the side of environmental integrity. Whereas UN Environmental Program policy requires precaution in the face of scientific uncertainty, World Trade Organization policy requires scientific certainty before precaution can be used. The conflict is obvious. In fact, there is gross lack of policy coordination across institutions. This article looks at some environmental strains and concludes that trade policy must address all aspects of human welfare, not merely the economic.


2000 ◽  
Vol 11 (2) ◽  
pp. 193-205
Author(s):  
Chris Miller

In this paper, I review the conceptual and legal obstacles faced by those who seek redress for health detriment which is though to be environmental in origin. I use two case studies concerned with radiation: one is related to energy production (paternal pre-conceptional irradiation of workers at a nuclear fuel reprocessing plant), the other involves electricity distribution (the alleged link between leukaemia and power cables). Judicial approaches to scientific uncertainty inherent in these two cases are examined. The more science points to a hitherto unimagined range of threats to human health, the fewer grounds remain for confidence in the capacity of tort to secure appropriate compensation for the putative victims.


2014 ◽  
Vol 27 (3) ◽  
pp. 511-529 ◽  
Author(s):  
Sudeepa Abeysinghe

ArgumentScientific uncertainty is fundamental to the management of contemporary global risks. In 2009, the World Health Organization (WHO) declared the start of the H1N1 Influenza Pandemic. This declaration signified the risk posed by the spread of the H1N1 virus, and in turn precipitated a range of actions by global public health actors. This article analyzes the WHO's public representation of risk and examines the centrality of scientific uncertainty in the case of H1N1. It argues that the WHO's risk narrative reflected the context of scientific uncertainty in which it was working. The WHO argued that it was attempting to remain faithful to the scientific evidence, and the uncertain nature of the threat. However, as a result, the WHO's public risk narrative was neither consistent nor socially robust, leading to the eventual contestation of the WHO's position by other global public health actors, most notably the Council of Europe. This illustrates both the significance of scientific uncertainty in the investigation of risk, and the difficulty for risk managing institutions in effectively acting in the face of this uncertainty.


2017 ◽  
Vol 48 (3) ◽  
pp. 608-641 ◽  
Author(s):  
Akos Rona-Tas ◽  
Antoine Cornuéjols ◽  
Sandrine Blanchemanche ◽  
Antonin Duroy ◽  
Christine Martin

Recently, both sociology of science and policy research have shown increased interest in scientific uncertainty. To contribute to these debates and create an empirical measure of scientific uncertainty, we inductively devised two systems of classification or ontologies to describe scientific uncertainty in a large corpus of food safety risk assessments with the help of machine learning (ML). We ask three questions: (1) Can we use ML to assist with coding complex documents such as food safety risk assessments on a difficult topic like scientific uncertainty? (2) Can we assess using ML the quality of the ontologies we devised? (3) And, finally, does the quality of our ontologies depend on social factors? We found that ML can do surprisingly well in its simplest form identifying complex meanings, and it does not benefit from adding certain types of complexity to the analysis. Our ML experiments show that in one ontology which is a simple typology, against expectations, semantic opposites attract each other and support the taxonomic structure of the other. And finally, we found some evidence that institutional factors do influence how well our taxonomy of uncertainty performs, but its ability to capture meaning does not vary greatly across the time, institutional context, and cultures we investigated.


Sign in / Sign up

Export Citation Format

Share Document